Prevalence of Fungal Foot Infections in Patients with Diabetes Mellitus Type 1 - Underestimation of Moccasin-Type Tinea

Abstract

In diabetic patients, mycotic infections may increase the risk of developing diabetic foot syndrome. However, few data are available on the prevalence of fungal foot infections in patients with diabetes. During a conference attended by patients with long-term diabetes, 95 individuals with type 1 diabetes mellitus (52 men, 43 women, mean disease duration 35.8 years) were examined for fungal infections of the feet. As well as frequency of infection and risk profiles, the level of patient awareness and preventive measures taken were assessed by means of a questionnaire. Clinically, 78 patients (82.1 %) showed probable pedal fungal infections, of which 84.6 % (66/78) were mycologically confirmed by direct microscopy and/or culture. Skin mycoses were found in 9 patients (toe webs 5, soles 4), onychomycosis in 29 patients and simultaneous infection of nails and skin in 28 patients (toe webs 8, soles 20). Thirty-seven (47.4 %) of these patients had positive cultures, particularly for the dermatophyte Trichophyton rubrum (69.2 % of isolates). A significant correlation was found between infection and gender (men more frequently affected) and the age of the patients. The actual frequency of mycoses was underestimated by the patients. This correlated with the assessment of their own knowledge level concerning fungal infections: 83.2 % of patients with skin mycoses and 88.4 % of those with onychomycosis of the feet felt that they needed more information about their disease. Marked mycoses on the soles were often considered to be dry skin by the patients. The high number of infections detected is especially remarkable in that this group of patients were highly motivated. It therefore appears that diabetics require more diagnostic, therapeutic and preventive care in terms of mycotic diseases than has been previously thought.

Diabetes mellitus - fungal foot infections - mocassin-type tinea

References

• 1 Abeck A, Hanecke E, Nolting S, Reinel D, Seebacher C. Onychomykose.  Deutsches Ärzteblatt. 2000;  97 1984-1986
• 2 Alteras I, Saryt E. Prevalence of pathogenic fungi in the toenails of diabetic patients.  Mycopathologica. 1979;  67 157-159
• 3 Buxton P K, Milne L JR, Prescott R J, Proudfoot M C, Stuart F M. The prevalence of dermatophyte infection in well-controlled diabetics and the response to Trichophyton antigen.  Br J Derm. 1996;  134 900-903
• 4 Detandt M, Nolard N. Fungal contamination of the floor of swimming pools, particularly subtropical swimming paradises.  Mycoses. 1995;  38 509-513
• 5 Farkas B, Paul C, Dobozy A, Hunyadi J, Horvaths A, Fekete G. Terbinafine (Lamisil) treatment of teonail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial.  Br J Derm. 2002;  146 254-260
• 6 Gupta A K, Konnikov N, MacDonald P, Rich P, Rodger N W, Edmonds M W, McManus R, Summerbell R C. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey.  Br J Derm. 1998;  139 665-671
• 7 Gupta Ak, Humke S. The prevalence and management of onychomycosis in diabetic patients.  Eur J Dermatol. 2000;  10 379-384
• 8 Haneke E. Fungal infections of the nail.  Sem Dermatol. 1991;  10 41-53
• 9 Joshi N, Caputo G M, Weitekamp M R, Karchmer A W. Infections in patients with diabetes mellitus.  N Engl J Med. 1999;  341 1906-1912
• 10 Levy L A. Epidemiology of onychomycosis in special risk populations.  J Am Podiatr Med Assoc. 1997;  87 546-550
• 11 Lugo-Somolinos A, Sanchez J L. Prevalence of dermatophytosis in patients with diabetes.  J Am Acad Dermatol. 1992;  26 408-410
• 12 Mayser P, Huppertz M, Papavassilis C, Gründer K. Hefen der Gattung Trichosporon - Identifizierung, Epidemiologie und Bedeutung bei dermatologischen Krankheitsbildern.  Hautarzt. 1996;  47 913-920
• 13 Rebell C, Taplin D. Dermatophytes. Their Recognition and Identification. Coral Gables, Fl. USA; University of Miami Press 1970
• 14 Rich P, Hare A. Onychomycosis in a special patient population: focus on the diabetic.  Int J Derm. 1999;  38 (Suppl 2) 17-19
• 15 Romano C, Massai L, Asta F, Signorini A M. Prevalence of dermatophytic skin and nail infections in diabetic patients.  Mycoses. 2001;  44 83-86
• 16 Wheat L J. Infections and diabetes mellitus.  Diabetes Care. 1980;  3 187-197
• 17 Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E, David M. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications.  Diabetes Care. 1998;  21 506-509